Clinical Trial Update: "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a combination of cindilizumab, bevacizumab, and Coenzyme I for Injection in unresectable hepatocellular carcinoma; current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cindilizumab
• Coenzyme I for Injection

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Unresectable Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN